Table 1.
Overall Function | Gene Name | Specific Function | Expression in Endo+ Versus Endo− Women | Citation |
---|---|---|---|---|
Innate Immune Response | ||||
ABR | Regulation of inflammation | ↑ | [26] | |
ASB13 | Innate immune response regulator | ↑ | [27] | |
TLR3a | Type I interferon induction | ↑ | [28] | |
NPR2 | C-type natriuretic peptide receptor which inhibits IFN-γ mediated gene expression | ↑ | [20] | |
PSG3 | IFN-γ responsiveness | ↑ | [29] | |
PVR (CD155) | NK cell effector function | ↑ | [30] | |
Mir620 | Targets CCL2 (MCP-1) | ↑ | [31] | |
COG6 | Regulation of inflammation | ↓ | [32] | |
MEIS2 | Myeloid cell differentiation | ↓ | [33] | |
PSG2 | IDO and TGF-β activity | ↓ | [34] | |
SLC5A1 | Glucose transport; innate immune cell function | ↓ | [35] | |
Adaptive Immune Response | ||||
PFKP | Glycolysis; T-cell function | ↑ | [23] | |
TLR3a | T-cell activation | ↑ | [36] | |
LARGE | T-cell development | ↓ | [24] | |
LGMN | T-cell activation; Class II antigen presentation | ↓ | [25] | |
Fibrosis | ||||
PLOD2 | Fibrotic enzyme | ↑ | [37] | |
TLR3a | Wound healing, fibrosis | ↑ | [38] | |
Proliferation and Apoptosis | ||||
CSE1L | Cell proliferation | ↓ | [39] | |
HERPUD1 | Apoptosis regulation | ↓ | [40] | |
TMEM192 | Apoptosis regulation | ↓ | [41] | |
XRN1 | Mitochondrial function | ↓ | [42] | |
Protein Synthesis and Degradation | ||||
ASB13 | Protein degradation | ↑ | [43] | |
HERPUD1 | Destruction of misfolded proteins | ↓ | [44] | |
MRM1 | Ribosomal RNA transferase | ↑ | [45] | |
MTRF1 | Mitochondrial translation | ↑ | [46] | |
UROS | Methionine synthesis | ↑ | [47] | |
WDR33 | Protein synthesis; cell differentiation | ↑ | [48] | |
Gene Regulation | ||||
HELTb | Transcriptional repressor | ↓ | [40] | |
ZNF512 | Transcription regulation | ↑ | [13] | |
Cell Membrane Formation and Function | ||||
PCDH17 | Cell adhesion | ↑ | [49] | |
PIGO | Cell membrane phospholipid synthesis | ↑ | ||
SLC26A5 | Membrane anion transporter | ↑ | [50] | |
CADPS | Vesicle exocytosis | ↓ | [s1] | |
CEPT1b | Cell membrane phospholipid synthesis | ↓ | [s2] | |
LR2BPb | Ligand endocytosis | ↓ | [s3] | |
Intracellular Energy Transfer | ||||
ABR | GTPase | ↑ | [s4] | |
NDUFB4 | NADH dehydrogenase | ↑ | [s5] | |
Female Reproductive Tract Health | ||||
OVGP1b | Fertilization, implantation, embryonic development | ↑ | [10] | |
NPR2 | Female reproductive tract development | ↑ | [s6] | |
GAS2L2 | Regulates ciliary orientation | ↑ | [s7] | |
Miscellaneous | EMR4 | Human pseudogene | ↑ | [s8] |
RPP38-DT | Unknown function | ↑ | ||
FAM162B | Unknown function | ↓ | ||
HEATR9 | Unknown function | ↓ | ||
KRTAP3-1 | Keratin-associated protein | ↓ | [s9] |
Abbreviations: IDO, indoleamine dioxygenase; IFN, interferon; MCP-1, monocyte chemoattractant protein-1; NK, natural killer; RNA, ribonucleic acid; TGF, transforming growth factor.
aTLR3 (P < .01) overlapped from primary and secondary analyses coincident with loci for chlamydial ascension.
bMediator genes (P < .01) from primary analysis of Centers for Disease Control and Prevention (CDC) cohort (P < 5 × 10E-05) coincident with loci for chlamydial ascension.
NOTE: The remaining mediator genes (P < .01) are from secondary analysis of CDC cohort (P < 5 × 10E-03) and Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) cohort (P < 5 × 10E-02) coincident with loci for chlamydial ascension.